Newton, Massachusetts, August 29, 2024- Abcuro, Inc., a clinical stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced that Alex Martin,..
Relevance: 3.8236656